CAS 10256-84-5

Formula: C28H20O8Si

InChI: InChI=1S/C28H20O8Si/c29-25(30)17-1-9-21(10-2-17)37(22-11-3-18(4-12-22)26(31)32,23-13-5-19(6-14-23)27(33)34)24-15-7-20(8-16-24)28(35)36/h1-16H,(H,29,30)(H,31,32)(H,33,34)(H,35,36)

InChI key: SVQPJYAUEQAOEU-UHFFFAOYSA-N

SMILES: C1=CC(=CC=C1C(=O)O)[Si](C2=CC=C(C=C2)C(=O)O)(C3=CC=C(C=C3)C(=O)O)C4=CC=C(C=C4)C(=O)O

4,4',4'',4'''-Silanetetrayltetrabenzoic acid

CAS: 10256-84-5

4,4',4'',4'''-Silanetetrayltetrabenzoic acid

Formula: C₂₈H₂₀O₈Si

Purity: 95%

Molecular weight: 512.54

Ref: 54-OR1001790

4,4',4'',4'''-Silanetetrayltetrabenzoic acid

CAS: 10256-84-5

Formula: C₂₈H₂₀O₈Si

Purity: 95%

Color and Shape: Solid

Molecular weight: 512.5391

Ref: IN-DA01XFZH

4,4′,4”,4”’-Silanetetrayltetrabenzoic acid

CAS: 10256-84-5

Purity: 95%

Molecular weight: 512.09

Ref: 10-F552289

Tetrakis(4-carboxyphenyl)silane

CAS: 10256-84-5

Tetrakis(4-carboxyphenyl)silane is a ligand that has been shown to bind to the active site of the nuclear transcription factor NF-κB, preventing it from binding to DNA. Tetrakis(4-carboxyphenyl)silane also has an affinity for inflammatory cytokines and can be used as an anti-inflammatory agent. Tetrakis(4-carboxyphenyl)silane was found to be effective in reducing infarction size when administered after myocardial infarction in rats. The crystal structure of tetrakis(4-carboxyphenyl)silane was determined by x-ray crystallography, showing that it is a semiconducting material with lanthanide properties.

Formula: C₂₈H₂₀O₈Si

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 512.5 g/mol

Ref: 3D-KAA25684